Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Jones

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Current Protocols|January 24, 2024
Create, Analyze, and Visualize Phylogenomic Datasets Using PhyloFisherRobert E Jones, Alexander K Tice, Marek Eliáš, et al.
Plos Biology|August 6, 2021
PhyloFisher: A phylogenomic package for resolving eukaryotic relationshipsAlexander K Tice, David Žihala, Tomáš Pánek, et al.
Scientific Reports|August 20, 2016
Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironmentPatrick H Lizotte, Robert E Jones, Lauren Keogh, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.
Nature Communications|February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpointsShohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
JCI Insight|October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypesPatrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Current Protocols|January 24, 2024
Create, Analyze, and Visualize Phylogenomic Datasets Using PhyloFisherRobert E Jones, Alexander K Tice, Marek Eliáš, et al.
Plos Biology|August 6, 2021
PhyloFisher: A phylogenomic package for resolving eukaryotic relationshipsAlexander K Tice, David Žihala, Tomáš Pánek, et al.
Scientific Reports|August 20, 2016
Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironmentPatrick H Lizotte, Robert E Jones, Lauren Keogh, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.
Nature Communications|February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpointsShohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
JCI Insight|October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypesPatrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 4